Granules India Ltd

With a decisive break above Rs 750, Granules India Ltd has surged to a fresh 52-week high of Rs 756 on 8 May 2026, marking a remarkable 72.25% gain over the past year. This rally is underpinned by a strong alignment of technical indicators and sustained price momentum, even as the broader Sensex trades lower by 0.41%.

Granules India Ltd has reached a significant milestone by touching its all-time high price of ₹755.85 on 08 May 2026, reflecting a sustained period of robust performance and investor confidence in the pharmaceuticals and biotechnology sector.

Surging past its previous peaks, Granules India Ltd touched a new 52-week high of Rs 736.6 on 6 May 2026, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of robust technical indicators and sustained buying interest, setting the stage for a compelling momentum narrative.

Granules India Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 6 May 2026 as its stock price touched an all-time high of Rs 731.90. This achievement reflects the company’s robust financial performance and sustained market momentum over recent periods.

Granules India Ltd., a vertically integrated pharmaceutical manufacturer specialising in active pharmaceutical ingredients and finished dosages, delivered a robust fourth-quarter performance for FY26, with consolidated net profit surging 32.59% year-on-year to ₹201.57 crores. The Hyderabad-based company, commanding a market capitalisation of ₹17,625 crores, demonstrated strong operational momentum with sequential profit growth of 34.19% from Q3 FY26, whilst revenue expanded 22.81% year-on-year to ₹1,470.61 crores.

Granules India Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, achieved a landmark by reaching its all-time high stock price of Rs.723 on 29 April 2026. This milestone reflects the company’s sustained performance and robust market presence, underscored by a series of positive financial and technical indicators.

Granules India Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

With a sustained nine-day rally culminating in a fresh 52-week high of Rs 713.1 on 29 Apr 2026, Granules India Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market by a significant margin.

With a decisive break above Rs 699.4 on 27 Apr 2026, Granules India Ltd has reached a fresh 52-week high, extending its impressive rally that has delivered over 54% returns in the past year. This milestone is underpinned by a confluence of strong technical indicators and sustained price momentum, setting the stock apart in the Pharmaceuticals & Biotechnology sector.

Surging to an intraday peak of Rs 696 on 23 Jun 2026, Granules India Ltd has marked a significant milestone by reaching a fresh 52-week high. This achievement caps a five-day winning streak that has propelled the stock up by 5.5%, outpacing its sector and reflecting robust technical momentum despite a broadly subdued market backdrop.

With a decisive break above Rs 689.8 on 22 Apr 2026, Granules India Ltd has reached a fresh 52-week high, extending its impressive 43.3% return over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained gains over the last four trading sessions, even as the broader Sensex faced downward pressure.

With a decisive breakout to Rs 668.9 on 20 Apr 2026, Granules India Ltd has surged to a fresh 52-week high, extending its impressive 45.87% return over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market indices.